These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2364642)

  • 41. [Which compressor should be used to deliver pentamidine aerosols with the Respirgard II?].
    Landman R; Faurisson F; Becquemin MH; Bouchikhi A; Girard PM
    Rev Mal Respir; 1991; 8(4):391-5. PubMed ID: 1924976
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pulmonary deposition of a nebulised aerosol during mechanical ventilation.
    Thomas SH; O'Doherty MJ; Fidler HM; Page CJ; Treacher DF; Nunan TO
    Thorax; 1993 Feb; 48(2):154-9. PubMed ID: 8493630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aerosol characterisation of nebulised liposomes co-loaded with erlotinib and genistein using an abbreviated cascade impactor method.
    Nimmano N; Somavarapu S; Taylor KMG
    Int J Pharm; 2018 May; 542(1-2):8-17. PubMed ID: 29496458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lung deposition of inhaled tobramycin with eFlow rapid/LC Plus jet nebuliser in healthy and cystic fibrosis subjects.
    Lenney W; Edenborough F; Kho P; Kovarik JM
    J Cyst Fibros; 2011 Jan; 10(1):9-14. PubMed ID: 20884302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is tapping jet nebulisers worthwhile?
    Everard ML; Evans M; Milner AD
    Arch Dis Child; 1994 Jun; 70(6):538-9. PubMed ID: 8048828
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lung deposition after inhalation with various nebulisers in preterm infants.
    Köhler E; Jilg G; Avenarius S; Jorch G
    Arch Dis Child Fetal Neonatal Ed; 2008 Jul; 93(4):F275-9. PubMed ID: 18192330
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An assessment of jet and ultrasonic nebulisers for the delivery of lactate dehydrogenase solutions.
    Khatri L; Taylor KM; Craig DQ; Palin K
    Int J Pharm; 2001 Oct; 227(1-2):121-31. PubMed ID: 11564546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of water as a diluent for bronchodilator nebuliser solutions.
    Kwong T; Town I; Windom H; Beasley R
    N Z Med J; 1990 Jun; 103(892):290-1. PubMed ID: 2366999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Nebuliser therapy].
    Demir G; Saryal S
    Tuberk Toraks; 2003; 51(3):325-32. PubMed ID: 15143414
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combinations of colistin solutions and nebulisers for lung infection management in cystic fibrosis patients.
    Buttini F; Rossi I; Di Cuia M; Rossi A; Colombo G; Elviri L; Sonvico F; Balducci AG
    Int J Pharm; 2016 Apr; 502(1-2):242-8. PubMed ID: 26854429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fungal contamination of nebuliser devices used by people with cystic fibrosis.
    Peckham D; Williams K; Wynne S; Denton M; Pollard K; Barton R
    J Cyst Fibros; 2016 Jan; 15(1):74-7. PubMed ID: 26104996
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of the efficacy of preservative free ipratropium bromide and Atrovent nebuliser solution.
    Rafferty P; Beasley R; Holgate ST
    Thorax; 1988 Jun; 43(6):446-50. PubMed ID: 2971274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In vitro comparison of DeVilbiss jet and ultrasonic nebulizers.
    Newman SP; Pellow PG; Clarke SW
    Chest; 1987 Dec; 92(6):991-4. PubMed ID: 3677844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Production, characterisation, and in vitro nebulisation performance of budesonide-loaded PLA nanoparticles.
    Amini MA; Faramarzi MA; Gilani K; Moazeni E; Esmaeilzadeh-Gharehdaghi E; Amani A
    J Microencapsul; 2014; 31(5):422-9. PubMed ID: 24697188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nebulisation of surfactants in an animal model of neonatal respiratory distress.
    Fok TF; al-Essa M; Dolovich M; Rasid F; Kirpalani H
    Arch Dis Child Fetal Neonatal Ed; 1998 Jan; 78(1):F3-9. PubMed ID: 9536832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Why nebulise for more than five minutes?
    O'Callaghan C; Clark AR; Milner AD
    Arch Dis Child; 1989 Sep; 64(9):1270-3. PubMed ID: 2510610
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aerosol kinetics and bronchodilator efficacy during continuous positive airway pressure delivered by face mask.
    Parkes SN; Bersten AD
    Thorax; 1997 Feb; 52(2):171-5. PubMed ID: 9059480
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Domiciliary nebuliser therapy--a valuable option in chronic asthma and chronic obstructive pulmonary disease?
    Godden DJ; Robertson A; Currie N; Legge JS; Friend JA; Douglas JG
    Scott Med J; 1998 Apr; 43(2):48-51. PubMed ID: 9717205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A study of the effects of sodium halides on the performance of air-jet and vibrating-mesh nebulizers.
    Najlah M; Vali A; Taylor M; Arafat BT; Ahmed W; Phoenix DA; Taylor KM; Elhissi A
    Int J Pharm; 2013 Nov; 456(2):520-7. PubMed ID: 23973409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nebulised siRNA encapsulated crosslinked chitosan nanoparticles for pulmonary delivery.
    Sharma K; Somavarapu S; Colombani A; Govind N; Taylor KM
    Int J Pharm; 2013 Oct; 455(1-2):241-7. PubMed ID: 23876499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.